Written Question·Department of Health and Social Care·UIN 110592
Idiopathic Pulmonary Fibrosis: Drugs
Tabled: 3 February 2026
Answered: 12 February 2026
Named DayQuestion
Michael Wheeler
Labour — Worsley and Eccles
To ask the Secretary of State for Health and Social Care, whether his Department has an estimate of the earliest possible date Jascayd (nerandomilast) could be available to idiopathic pulmonary fibrosis patients.
Answer
Dr Zubir AhmedNerandomilast does not currently have a United Kingdom marketing authorisation for use in the treatment of idiopathic pulmonary fibrosis. It is currently being evaluated by the National Institute for Health and Care Excellence (NICE) which makes recommend...
ⓘ
This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 110592) →